User Fees Won't Save FDA Approvals From Shutdown's Snare

Given its reliance on industry fees, the U.S. Food and Drug Administration will be less hampered by the government shutdown than other federal agencies, but attorneys say that funding and manpower...

Already a subscriber? Click here to view full article